text:
Thanks for helping us sort this video!
Thanks for helping us associate the correct Pornstars to this video!
Help Us: Do these Pornstars appear in this video?
Pornstar Name:
All Comments (4)
Mais c'est quoi la marque d cette huile ??? merci
This is the kind of stuff we need way far more of! Roughly 99.9 percent of porn sites always have only the same boring junk all the time. All those endless pictures and videos of only sexual intercorse, oral sex, and such, especially without any touching of the boobs and/or other extremities, they get old and boring very quickly. It's as if a woman's boobs may as well be an instant turn off for all men or something.
miam miam elle à de superbe seins avec de gros tétons


text:
Skip to comments.Squeal Like a Pig: Joe Biden Describes Disturbing Deliverance Scene to Abuse Victims
Posted on 05/02/2013 11:28:39 AM PDT by ColdOne
Vice President Joe Biden drew parallels with the movie Deliverance while addressing a benefit dinner for a volunteer legal group that helps domestic violence survivors.
Bidens daughter-in-law, Kathleen Biden, is a co-chair of the group. Calling him Pop, she introduced the veep to the crowd packed with even more Bidens.
According to the White House pool report,
(Excerpt) Read more at pjmedia.com ...
Biden, the gift that keeps on giving.
Really, how classless can one person be?
has Joe ever had a Stroke ?
LOL. Because if Bobby complained, the sheriff would have charged him with an anti-gay hate crime.
Sometimes ... there just are no words.
This idiot is an embarrassment. If he had an "R" next to his name he'd be crucified non-stop 24 hrs a day.
Has a VP ever been impeached? I knew Agnew and maybe one or two others quit or didnt run but sheesh!
His plugs have rooted deep into his brain.
Subconsciously, I reckon we know what Old Joe
would like to do to all of us.
Joe is a gift that never stops giving.
He's a sicko. Dementia?
It's hard to say as Biden sets a new standard every day.
But to give a shout out to our vast support in the Gay Community, in truth, Bobby... kinda liked it after all--
Golly, Bend? Can you really... make this stuff up?
Hey! I've had two and they didn't make me a classless idiot! : ) What an embarrassment this administration is to all Americans.
I've probably met someone this stupid, but I can't recall.
Still, I'd rather him be preezy than the commie.
Before he was VP, the media portrayed him as the elder statesman. I couldn't believe it when Howie Carr said he was gaffe-prone.
Joe had a minor role in that movie.
It was young Joe who played the incestuously conceived albino retard who could, at least, play the banjo.
Doctors did a brain scan a few years ago - they didn't find anything. :=)
And I see the vision of a photoshop of Slo Joe on Ned Beatty's character ....
Here's Joe pickin' and grinnin':
Biden had brain aneurysm surgery in 1988.
has Joe ever had a Stroke ?....Yeah, but his hand slipped and he hit himself in the head.
Hey! Stop picking on Joe and wishing him impeached while the biggest and worst POS in America's history prances about the oval orifice delivering some of the most ignorant lines ever uttered by a president.
(and that's saying a 'bunch'.)
And this dumbass is Vice President of the United States???
Stroke? Yeah basically he survived a brain aneurysm - don't really know how "off" he was before this but I do know this - it couldn't possibly have helped any.
1- Joe Biden survived a brain aneurysm
In the winter of 1988 Joe Biden was chairing the Senate Judiciary Committees hearings on Supreme Court nominee Anthony Kennedy when he began to experience neck pain. The pain worsened and was joined by other problems, including nausea. Eventually, Joe Biden went to the hospital.
Turns out Biden had whats called a berry aneurysm at the base of his brain that was leaking blood into the space between his brain and the brains protective lining. An emergency, six-hour surgery at Walter Reed Medical Center took care of the problem and in this regard Joe Biden lucked out, since most people with a brain aneurysm get no advanced warning — it simply bursts, resulting in paralysis, mental impairment, coma or death.
Ouch. Please, someone make the stupid end. It really hurts.
He survived to cause us paralysis?...
Joe...He sure got a pretty mouth
Joe had a minor role in that movie.
It was young Joe who played the incestuously conceived albino retard who could, at least, play the banjo.
Actually, you're thinking of James Carville
All you women out there: Daughters are wonderful. Granddaughters are better, Biden said. When theyre 12 to 14, a dad puts his beautiful little daughter to bed. And then the next morning, theres a snake in the bed.
I wash myself with a rag on a stick.
Doctors discovered that Biden's brain was one large tumor, so they removed the whole thing.
keyboard spew alert
Of course he's had a stroke ~ probably dozens of them but the nylon mesh wrapped around his arteries serving his brain keep the juice in.
Biden is 0bama's way of mocking old white people. That's the ONLY reason 0bama chose him; To mock, belittle, and make an embarrassment of old white males.
The entertaining part of this is Biden the Slow fancies himself as brilliant, while most are pretty convinced he's a quart low. Sort of the exact opposite of Peter Sellers in "Being There."
Mentioning Joe Biden in the same sentence with banjo players is deeply offensive........to all banjo players.
Joe and James did have the same mother, didn't they?
>Biden is 0bamas way of mocking old white people. Thats the ONLY reason 0bama chose him; To mock, belittle, and make an embarrassment of old white males.<
I disagree. As horrible as Obama is as a president, few people would want Biden in the White House.
He's a great insurance card against impeachment.
Wait, wut? Joe's granddaughters go to bed and wake up with Joe's snake?
Definatley POTUS material for 2016 The USA cannot go up so we might as well demise sooner than later!
Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.

subset: commoncrawl


text:
Email this article from PlasticsNews.com
Health Canada: BPA is safe in food packaging
OTTAWA (Oct. 1, 12:45 p.m. ET) — A report by Health Canada says there is no health risk from exposure to bisphenol A in food packaging — even though the Canadian government banned BPA from baby bottles four years ago.
More Events > Upcoming Events
Most Popular
Progressive fights counterfeiters at Chinaplas
NEWS Tuesday, May 03
Sumitomo Demag introduces SEEV-A all-electric presses
NEWS Wednesday, May 04
N.E.W. buys blow molder Fulcrum
NEWS Tuesday, May 03
Maroon buys specialty distributor US Chemicals
NEWS Tuesday, May 03
Bumper to Bumper: Automakers, suppliers using plastics to improve interiors
MULTIMEDIA01 Wednesday, May 04


text:
CHEST publishes select peer-reviewed, accepted manuscripts Online First each week. The media embargo is lifted on the date of Online First publication. Final, edited versions will appear in a numbered issue of CHEST and may contain substantive changes. We encourage readers to check back for the final article. Online First papers are indexed in PubMed and by search engines, but the information, including the final title and author list, may be updated on final publication.
Hospitalizations for aspiration pneumonia have doubled among the elderly. Using a bedside water swallow test (WST) to screen for swallowing-related aspiration can be efficient and cost-effective for preventing additional comorbidities and mortality. We evaluated screening accuracy of bedside WSTs used to identify patients at risk for dysphagia-associated aspiration.
Sixteen online databases, Google Scholar, and known content experts through May 2015 were searched. Only prospective studies with patients ≥18 years old given WST screenings validated against nasoendoscopy or videofluoroscopy were included. Data extraction used dual masked extraction and quality assessment following MOOSE guidelines.
Airway response (e.g., coughing/choking) with or without voice changes (e.g., wet/gurgly voice quality) was used to identify aspiration during 3 different bedside WSTs. Pooled estimates for single sip volumes (1-5 ml) were 71% sensitive (95%CI, 63%-78%) and 90% specific (95%CI, 86%-93%). Consecutive sips of 90-100 ml trials were 91% sensitive (95%CI, 89%-93%) and 53% specific (95%CI, 51%-55%). Trials of progressively increasing volumes of water were 86% sensitive (95%CI, 76%-93%) and 65% specific (95%CI, 57%-73%). Airway response with voice change improved overall accuracy in identifying aspiration.
Currently used bedside WSTs offer sufficient, although not ideal, utility in screening for aspiration. Consecutive sips with large volumes in patients who did not present with overt airway responses or voice changes appropriately ruled out risk of aspiration. Small volumes with single sips appropriately ruled in aspiration when clinical signs were present. Combining these bedside approaches may offer improved screening accuracy, but further research is warranted.
Smoking tobacco increases the risk of respiratory disease in adults and children, but communicating the magnitude of these effects in a scientific manner that is accessible and usable by public and policymakers presents a challenge. We have therefore summarised scientific data on the impact of smoking on respiratory diseases to provide the content for a unique resource, SmokeHaz.
We conducted systematic reviews and meta-analyses of longitudinal studies (published to 2013) identified from electronic databases, grey literature, and experts. Random effect meta-analyses were used to pool the findings.
We included 216 papers. Among adult smokers, we confirmed substantially increased risks of lung cancer (Risk Ratio (RR) 10.92, 95% CI 8.28-14.40; 34 studies), COPD (RR 4.01, 95% CI 3.18-5.05; 22 studies) and asthma (RR 1.61, 95% CI 1.07-2.42; 8 studies). Exposure to passive smoke significantly increased the risk of lung cancer in adult non-smokers; and increased the risks of asthma, wheeze, lower respiratory infections, and reduced lung function in children. Smoking significantly increased the risk of sleep apnoea, and asthma exacerbations in adult and pregnant populations; and active and passive smoking increased the risk of tuberculosis.
These findings have been translated into easily digestible content and published on the SmokeHaz website (www.smokehaz.eu).
Platelet transfusions are commonly used in critically ill patients, but transfusion thresholds, count increments, and predictors of ineffectual transfusions remain unclear.
This retrospective study included consecutive adult non-oncology patients who received platelet transfusions in intensive care units (ICU) in 3 Canadian academic hospitals between 2006 and 2015. Data were collected from a validated transfusion database. We determined independent predictors of ineffectual platelet transfusions, defined as transfusions that raised platelet counts by < 5 x109/L. Reasons for transfusion were adjudicated in a subgroup of patients who were transfused despite normal platelet counts.
We identified 7,320 ICU admissions (n=7,073 patients) during which 15,879 platelet transfusions were administered. Most admissions (78.7%) were for cardiac surgery. Based on 5,700 analyzable transfusions, median pre-transfusion platelet count was 87 x109/L [interquartile range (IQR) 57-130]. For 79.6% and 17.8% of transfusions, pre-transfusion platelet count was ≥50 x109/L and ≥150 x109/L, respectively. Reasons for transfusion despite normal platelet count were active bleeding or surgery in patients receiving anti-platelet agents or anticoagulants. Median platelet count increment was 23 x109/L (IQR 7-44); and 21.8% of transfusions were ineffectual. ABO incompatibility, sepsis, liver disease, red cell and cryoprecipitate transfusion were associated with poor count increment.
Platelet transfusions were commonly used in ICU when platelet counts were ≥50 x109/L. One platelet transfusion increased platelet count by 23 x109/L. One in 5 transfusions was ineffectual and ABO incompatibility was identified as a modifiable risk factor. These data can help direct efforts to reduce platelet overuse and improve transfusion quality.
Increased expression of the human epididymis protein 4 (HE4) was previously described in lung biopsy samples from cystic fibrosis (CF) patients, but it has remained unknown whether serum HE4 concentrations are elevated in CF.
Seventy-seven children with CF from six Hungarian CF centers and 57 adult CF patients from a Czech center were enrolled. In addition, 94 individuals with non-CF lung diseases, and 117 normal controls without pulmonary disorders were analyzed. Serum HE4 was measured by an immunoassay and its expression was further investigated via the quantification of HE4 mRNA using RT-qPCR in CF versus non-CF respiratory epithelium biopsies. The expression of the potential regulator miR-140-5p was analyzed using an UPL-based RT-qPCR assay. HE4 was measured in the supernatants from unpolarized and polarized cystic fibrosis bronchial epithelial (CFBE) cells expressing wt- or F508del-CFTR.
Serum HE4 levels were significantly elevated in children with CF (99.5 [73.1-128.9] pmol/L) compared to controls (36.3 [31.1-43.4] pmol/L; P<0.0001). This observation was replicated in CF adults (115.7 [77.8-148.7] pmol/L; P<0.0001). In contrast, abnormal but lower HE4 concentrations were found in cases of severe bronchitis, asthma, pneumonia or bronchiectasis. In CF patients, the concentrations of HE4 were positively correlated with overall disease severity and C-reactive protein concentrations, while a significant inverse relationship was found between HE4 and the spirometric FEV1 value. Relative HE4 mRNA levels were significantly upregulated (P=0.011) with a decreased miR-140-5p expression (P=0.020) in the CF versus non-CF airway biopsies. There were 2-fold higher HE4 concentrations in the supernatant of polarized F508del-CFTR CFBE cells compared to wt cells.
HE4 serum levels positively correlate with the overall severity of CF and the degree of pulmonary dysfunction. HE4 may thus be utilized as novel inflammatory biomarker and possibly also as measure of treatment efficacy in CF lung disease.
Interstitial lung disease (ILD) is a frequent pulmonary manifestation and an important cause of morbidity and mortality in patients with idiopathic inflammatory myopathy. Myositis related ILD presents a therapeutic challenge for clinicians, as there are no available guidelines to help with management decisions. This review covers the existing evidence on the pharmacologic and non-pharmacologic management of myositis related ILD, highlighting the lack of randomized controlled data to guide treatment. Given the absence of existing guidelines to inform treatment decisions, we provide a comprehensive summary, including dosing, side effects, and suggested monitoring, of the commonly used immunosuppressive agents and a proposed treatment algorithm, based on the existing literature.
Non-ventilated hospital-acquired pneumonia (NVHAP) is a serious nosocomial infection increasingly attributed to antibiotic-resistant bacteria.
A retrospective case-control study comparing patients with and without NVHAP from 1 January 2014 to 31 December 2014 at Barnes-Jewish Hospital, a 1300-bed urban academic medical center in St. Louis, Missouri.
174 consecutive patients with NVHAP were enrolled. A random sample of 696 control patients matched on age, gender, race, and hospital admission date were selected from a total of 5322 potential matched controls. NVHAP was pathogen-negative in 98 cases (56.3%). Respiratory viruses were identified in 42 (24.1%) patients, Gram-negative bacteria in 25 (14.4%) patients, and Gram-positive bacteria in 20 (11.5%) patients. Individuals developing NVHAP were more likely to die (15.5% versus 1.6%; P < 0.01), require intensive care (56.3% versus 22.8%; P < 0.01), mechanical ventilation (19.0% versus 3.9%; P < 0.01), and to have longer hospital length of stay (15.9 days [9.8 days, 26.3 days] versus 4.4 days [2.9 days, 7.3 days]; P < 0.01). The case-control study identified a strong association between hospital mortality and NVHAP, with NVHAP patients having an 8.4 times greater odds of death (95% CI, 5.6 – 12.5).
The occurrence of NVHAP was associated with significant increases in mortality, the use of intensive care, mechanical ventilation, and hospital length of stay. We also found that respiratory viruses were an important etiology of NVHAP. These findings suggest that efforts aimed at the successful prevention of NVHAP could improve patient outcomes and reduce health care costs.
Predicting intensive care need among adults with community-acquired pneumonia (CAP) remains challenging.
Using a multicenter prospective cohort study of adults hospitalized with CAP, we evaluated the association of serum procalcitonin concentration at hospital presentation with the need for invasive respiratory and/or vasopressor support (IRVS) within 72 hours. Logistic regression was used to model this association, with results reported as the estimated risk of IRVS for a given procalcitonin concentration. We also assessed whether the addition of procalcitonin changed the performance of established pneumonia severity scores, including the pneumonia severity index and American Thoracic Society minor criteria, for prediction of IRVS.
Of 1770 enrolled patients, 115 (6.5%) required IRVS. Using the logistic regression model, procalcitonin concentration had a strong association with IRVS risk. Undetectable procalcitonin (<0.05 ng/ml) was associated with a 4.0% (95% CI: 3.1%, 5.1%) risk of IRVS. For concentrations <10 ng/ml, procalcitonin had an approximate linear association with IRVS risk; for each 1 ng/ml increase in procalcitonin, there was a 1-2% absolute increase in the risk of IRVS. With a procalcitonin concentration of 10 ng/ml, the risk of IRVS was 22.4% (95% CI: 16.3%, 30.1%) and remained relatively constant for all concentrations > 10 ng/ml. When added to each pneumonia severity score, procalcitonin contributed significant additional risk information for prediction of IRVS.
Serum procalcitonin concentration was strongly associated with the risk of requiring IRVS among adults hospitalized with CAP and is potentially useful for guiding decisions about intensive care unit admission.
Chronic obstructive pulmonary disease (COPD) is characterized by chronic inflammation. In vitro and ex-vivo observations suggest that this inflammatory response is partially resistant to the effect of corticosteroids, and that low-dose theophylline can restore this response via enhancement of histone deacetylase activity (HDAC). Whether or not this occurs in vivo, and what are its potential clinical consequences is unclear.
To determine if low-dose theophylline on top of inhaled long-acting beta-agonists /corticosteroids (ICS) treatment in COPD patients: (1) enhances HDAC activity and the anti-inflammatory effects of ICS in vivo; (2) reduces the concentration of inflammatory markers; and, (3) reduces exacerbation frequency.
In this prospective, double-blind, placebo-controlled clinical trial, we randomized COPD patients (FEV1<50% predicted plus at least one hospitalization due to exacerbation in the previous year) to ICS plus theophylline 100 mg bid or matched placebo. We determined at baseline and at the end of 52 weeks follow-up: (1) HDAC activity in blood monocytes and sputum macrophages; (2) the concentration of several inflammatory markers (interleukin (IL)-8, IL-6, IL-1β and tumour necrosis factor alpha (TNFα)) in serum and sputum supernatant; and, (3) the rate of exacerbations and side effects.
70 patients were randomized, 36 in the theophylline and 34 in the placebo arm. HDAC activity and levels of the inflammatory markers were not different in both arms either at baseline or after 52 weeks. Likewise, the rate of exacerbations during follow-up was similar in both groups.
The combination of low dose oral theophylline and ICS does not enhance the anti-inflammatory properties of ICS in vivo nor influence exacerbation rate.
The vascular safety of electronic cigarettes still needs to be clarified. We compared the impact of electronic cigarettes versus traditional cigarettes on oxidative stress and endothelial function in healthy smokers and non-smoker adults.
We performed a cross-over single-blind study in 40 healthy subjects (20 smokers, 20 non-smokers, matched for age and sex). Firstly, all subjects smoked T-cigarettes. One week later the same subjects smoked an E-cigarette with the same nominal nicotine content. Blood samples were drawn just before and after smoking and markers of oxidative stress, nitric oxide bioavailability and vitamin E levels were measured. Flow-mediated dilatation (FMD) was also measured.
Smoking both electronic cigarettes and traditional cigarettes led to a significant increase of the levels of sNox2-dp, 8-isoPGF2α and to a significant decrease of NO bioavailability, vitamin E levels and FMD. Generalizing estimating equation analysis confirmed that all markers of oxidative stress and FMD were significantly affected by smoking and showed that the biologic effects of electronic cigarettes versus traditional cigarettes on vitamin E levels (p=0.413) and FMD (p=0.311) were not statistically different. On the other hand, electronic cigarettes appeared to have a lesser impact than traditional cigarettes on levels of sNox2-dp (p=0.001), 8-isoPGF2α (p=0.046) and NO bioavailability (p=0.001).
Our study demonstrates that both cigarettes have unfavorable effects on markers of oxidative stress and FMD after single use, although E-cigarette appeared to have a lesser impact. Future studies are warranted to clarify the chronic vascular effects of E-cigarette smoking.
Problems with the use of inhalers by patients were noted shortly after the launch of the metered dose inhaler (MDI) and persist today. We aimed to assess the most common errors in inhaler use over the last 40 years in patients treated with MDI or dry powder inhalers (DPI).
A systematic search for articles reporting direct observation of inhaler technique by trained personnel covered the period 1975 to 2014. Outcomes were nature and frequencies of the three most common errors; the percentage of patients demonstrating correct, acceptable, or poor technique; and variations in these outcomes over these 40 years and when partitioned into years 1–20 and 21–40. Analyses were conducted in accordance with PRISMA and STROBE recommendations.
Data were extracted from 144 articles reporting on a total number of 54 354 subjects performing 59 584 observed tests of technique. The most frequent MDI errors were in co-ordination (45% (95% CI 41–49%)), speed and/or depth of inspiration (44% (40–47%)), and no post-inhalation breath-hold (46% (42–49%)). Frequent DPI errors were incorrect preparation in 28% (26–33%), no full expiration before inhalation in 46% (42–50%), and no post-inhalation breath-hold in 37% (33–40%). The overall prevalence of correct technique was 31% (28–35%); of acceptable, 41% (36–47%); and of poor, 31% (27–36%). There were no significant differences between the first and second twenty-year periods of scrutiny.
Incorrect inhaler technique is unacceptably frequent and has not improved over the past 40 years, pointing to an urgent need for new approaches to education and drug delivery.
Pseudomonas aeruginosa is not a frequent pathogen in Community Acquired Pneumonia (CAP). However, in patients with severe CAP, P. aeruginosa can be the etiology in 1.8% to 8.3% of patients, with a case-fatality rate of 50% to 100%. We describe the prevalence, clinical characteristics, outcomes and risk factors associated with CAP due to multidrug and non-multidrug resistant P. aeruginosa.
Prospective observational study of 2023 consecutive adult CAP patients with definitive etiology.
P. aeruginosa was found in 77 (4%) of the 2023 cases with microbial etiology. In 22 (32%) of the 68 cases of P. aeruginosa with antibiogram data, the isolates were multidrug-resistant (MDR). Inappropriate therapy was present in 49 (64%) cases of P. aeruginosa CAP, including 17/22 (77%) cases of MDR P. aeruginosa CAP. Male sex, chronic respiratory disease, C-reactive protein <12.35 mg/dL, and PSI risk class IV – V were independently associated with P. aeruginosa CAP. Prior antibiotic treatment was more frequent in MDR P. aeruginosa CAP compared with non-MDR P. aeruginosa (58% vs. 29%, p=0.029), and was the only risk factor associated with CAP due to MDR P. aeruginosa. In the multivariate analysis, age ≥65 years, CAP due to P. aeruginosa, chronic liver disease, neurologic disease, nursing-home, criteria of ARDS, acute renal failure, ICU admission, and inappropriate empiric treatment were the factors associated with 30-day mortality.
P. aeruginosa is an individual risk factor associated with mortality in CAP. The risk factors described can help clinicians to suspect P. aeruginosa and MDR P. aeruginosa.
Negative pressure pulmonary edema (NPPE) or post-obstructive pulmonary edema is a well-described cause of acute respiratory failure that occurs after intense inspiratory effort against an obstructed airway, usually from upper airway infection, tumor, or laryngospasm. Patients with NPPE generate very negative airway pressures, which augment transvascular fluid filtration and precipitate interstitial and alveolar edema. Pulmonary edema fluid collected from most patients with NPPE has a low protein concentration, suggesting hydrostatic forces as the primary mechanism for the pathogenesis of NPPE. Supportive care should be directed at relieving the upper airway obstruction with endotracheal intubation or cricothyroidotomy, institution of lung protective positive pressure ventilation, and diuresis unless the patient is in shock. Resolution of the pulmonary edema is usually rapid, in part because alveolar fluid clearance mechanisms are intact. In this review, we discuss the clinical presentation, pathophysiology, and management of negative pressure or post-obstructive pulmonary edema.
The critically ill, asplenic patient presents a variety of management challenges. Historically, the focus of the care of the asplenic population has been the prevention and management of infection, including the often-fatal overwhelming post-spenectomy infection with encapsulated organisms such as Streptococcus pneumoniae. Recently, however, there has been increasing recognition of the spleen's function in areas outside of immunity, as the asplenic state has been recognized as a risk factor for such vascular complications as thrombosis and pulmonary hypertension due to dysregulated inflammation and coagulation. Because of the relatively small size of this population and the relative infrequency with which critical illness occurs in it, there are few controlled trials which can serve as a basis for therapeutic maneuvers; thus, optimal management requires an astute clinician with an understanding of the pathogenetic mechanisms underlying the reported consequences of splenectomy. The purpose of this review is to explore the pathophysiology of the asplenic state – impairment in adaptive immunity, loss of blood filtration, endothelial dysfunction, and dysregulated coagulation – and how it leads to infection, thrombosis, and pulmonary hypertension, as well as to discuss the implications of these conditions on the management of the critically ill, splenectomized patient.
Survivorship after critical illness is an increasingly important health care concern as intensive unit care (ICU) utilization continues to increase while ICU mortality is decreasing. Critical illness survivors experience marked disability and impairments in physical and cognitive function that persist for years after their initial ICU stay1-7. Newfound impairment is associated with increased healthcare costs and utilization, reductions in health related quality of life and prolonged unemployment5,8,9. Weakness, critical illness neuropathy and/or myopathy, and muscle atrophy are common in critically ill patients with up to 80% of patients admitted to the ICU developing some form of neuromuscular dysunction1,10,11. ICU acquired weakness (ICUAW) is associated with longer durations of mechanical ventilation and hospitalization along with greater functional impairment for survivors. Although there is increasing recognition of ICUAW as a clinical entity, significant knowledge gaps exist around identifying high risk patients for its development and understanding its role in long-term outcomes after critical illness. This review addresses the epidemiology and pathophysiology of ICUAW, highlights the diagnostic challenges associated with its diagnosis in critically ill patients and proposes a novel strategy for identifying ICUAW.
A comprehensive evaluation of temporal trends in the treatment of patients who have deep vein thrombosis (DVT) may assist with identification of modifiable factors that contribute to short-term outcomes.
We assessed temporal trends in length of hospital stay and use of pharmacological and interventional therapies among 26,695 adults with DVT enrolled in the RIETE registry between 2001 and 2014. We also examined temporal trends in risk-adjusted rates of all-cause, PE-related, and bleeding-related death to 30-days after diagnosis.
The mean length of hospital stay decreased from 9.0 days in 2001-2005 to 7.6 days in 2010-2014 (P <0.01). For initial DVT treatment, the use of low-molecular weight-heparin decreased from 98% to 90% (P <0.01). Direct oral anticoagulants use increased from 0.5% in 2010 to 13.4% in 2014 (P <0.001). Risk-adjusted rates of 30-day all-cause mortality decreased from 3.9% in 2001-2005 to 2.7% in 2010-2014 (adjusted rate ratio per year, 0.84; 95% confidence interval [CI], 0.74 to 0.96; P <0.01). VTE-related mortality showed a non-statistically significant downward trend (adjusted rate ratio per year, 0.70; 95% CI, 0.44 to 1.10; P =0.13), whereas 30-day bleeding-related mortality significantly decreased from 0.5% in 2001-2005 to 0.1% in 2010-2014 (adjusted rate ratio per year, 0.55; 95% CI, 0.40 to 0.77; P <0.01).
This international registry-based temporal analysis identified reductions in length of stay for adults hospitalized for DVT. The study also found a decreasing trend in adjusted rates of all-cause and bleeding-related mortality.
Recent studies have identified processes that are associated with more favorable length of stay outcomes when an ICU telemedicine program is implemented. Despite these studies, the relation of the acceptance of ICU telemedicine management services by individual ICUs to length of stay (LOS) outcomes is unknown.
This is a single ICU telemedicine center study that compares length of stay outcomes among 3 groups of intensivist staffed mixed medical surgical ICUs that used alternative co-management strategies. The proportion of provider orders recorded by an ICU telemedicine provider to all recorded orders were compared among ICUs that used a monitor and notify co-management approach, a direct intervention with timely notification process, and ICUs that used a mix of these two approaches. The primary outcome was acuity adjusted hospital length of stay.
ICUs that used the direct intervention with timely notification strategy had a significantly larger proportion of provider orders recorded by ICU telemedicine physicians than the mixed methods of co-management group, which had a larger proportion than ICUs that used the monitor and notify method (p < 0.001). Acuity-adjusted hospital LOS was significantly lower for the direct intervention with timely notification co-management strategy 0.68 (.65 to .70) compared to the mixed methods group (0.70 (.69 to .72); p =0.01), which was significantly lower than the monitor and notify group (0.83 (.80 to .86); p< 0.001).
Direct intervention with timely notification strategies of ICU telemedicine co-management were associated with shorter LOS outcomes than monitor and notify co-management strategies.
Previous meta-analyses of PAH-specific therapy for pulmonary arterial hypertension (PAH) pooled PAH-specific combination therapy and monotherapy together. The flaw might threaten the authenticity of their findings.
PubMed, Embase, and the Cochrane Library were searched for randomized controlled trials (RCTs) that evaluated any PAH-specific medications in the treatment of PAH. We calculated odds ratio (OR) with 95% confidence intervals (CIs) for dichotomous data and standardized mean differences for continuous data.
In total, 35 RCTs involving 6,702 patients were included. In monotherapy vs placebo/conventional therapy, significance was obtained in mortality reduction (OR:0.50; 95%CI:0.33-0.76; P=0.001), six-minute walk test (6MWD) (MD:31.10m; 95%CI: 25.40 to 36.80; P <0.00001), NYHA/WHO functional class (OR:2.48; 95%CI:1.51-4.07; P=0.0003), hemodynamic based on mean pulmonary artery pressure (mPAP), pulmonary vascular resistance (PVR), cardiac index (CI), and incidence of withdrawal due to adverse effects. In combination therapy vs monotherapy, significance was reached for 6MWD(MD:19.96m; 95%CI:15.35-24.57; P<0.00001), functional class(OR:1.65; 95%CI:1.20-2.28; P=0.002), hemodynamic, incidence of withdrawal due to adverse effects(OR: 2.01; 95%CI:1.54-2.61; P<0.00001 ), but not for mortality reduction(OR:0.98; 95%CI:0.57-1.68; P=0.94).
Our meta-analysis revealed that PAH-specific medications monotherapy could improve mortality, exercise capacity, functional class and hemodynamic when compared with placebo or conventional therapy. However, combination therapy could further improve exercise capacity, functional class and hemodynamic status compared with monotherapy, but had no proven effect on mortality. Combination therapy had a much higher incidence of withdrawal due to adverse effects than monotherapy.
This phase 3 study further characterizes the efficacy and safety of reslizumab (a humanized anti–interleukin-5 monoclonal antibody) in patients aged 12-75 years with asthma inadequately controlled by at least a medium-dose inhaled corticosteroid, and blood eosinophils ≥400cells/μL.
Patients were randomized to receive reslizumab 0.3 or 3.0mg/kg or placebo once/every 4 weeks/16 weeks. Primary endpoint was change from baseline in pre-bronchodilator forced expiratory volume in 1 sec (FEV1) over 16 weeks. Secondary endpoints included forced vital capacity (FVC), forced expiratory flow at 25-75% of FVC (FEF25-75%), patient-reported control of asthma symptoms, short-acting beta agonist (SABA) use, blood eosinophil levels, and safety.
Reslizumab significantly improved FEV1 (difference vs placebo [reslizumab 0.3 and 3.0mg/kg]:115mL[95% CI 16-215; P= .0237] and 160mL[95% CI 60-259; P= .0018]). Clinically meaningful increases in FVC (130mL) and FEF25-75% (233mL/s) were observed with reslizumab 3.0mg/kg. Reslizumab improved Asthma Control Questionnaire (ACQ) and Asthma Quality of Life Questionnaire (AQLQ) versus placebo (greater effects seen with 3.0mg/kg; P<0.05). The minimally important difference was reached for AQLQ (reslizumab 3.0mg/kg) but not ACQ. Asthma Symptom Utility Index and SABA use were improved with reslizumab. The most common adverse events were asthma worsening, headache, and nasopharyngitis; most were mild-to-moderate in severity.
Reslizumab improved lung function, asthma control and symptoms, and quality of life, and was well tolerated in patients with inadequately controlled asthma (despite standard therapy), and elevated blood eosinophils. Overall, the 3.0mg/kg dose of reslizumab provided greater improvements in asthma outcomes (vs 0.3mg/kg), with comparable safety.
Little is known on the effects of long-term nasal low flow oxygen (NLFO) on mucus and symptoms and how this is affected by dry or cold humidified gas. The aim of this study was to investigate the effects of dry-NLFO and cold bubble humidified-NLFO on nasal mucociliary clearance (MCC), mucus properties, inflammation and symptoms in subjects with chronic hypoxemia requiring long-term domiciliary oxygen therapy.
Eighteen subjects (mean 68 years, 7 male, 66% COPD) initiating NLFO were randomized to Dry-NLFO (n=10) or Humidified-NLFO (n=8). Subjects were assessed at baseline, 12 hours, 7 days, 30 days, 12 months and 24 months by measuring nasal MCC by saccharine transit test, mucus contact angle (surface tension), inflammation (cells and cytokine concentration in nasal lavage) and symptoms by the Sino-Nasal Outcome Test-20.
Nasal MCC decreased significantly (40% longer saccharine times) and similarly in both groups over study. There was a significant association between impaired nasal MCC and lung function decline. Nasal lavage showed an increased proportion of macrophages, IL-8 and EGF concentrations with decreased IL-10 during the study. No changes in the proportion of ciliated cells or contact angle were observed. Coughing and sleep symptoms decreased similarly in both groups. There were no outcome differences when comparing dry to cold bubble humidified NLFO.
In subjects receiving chronic NLFO, cold bubble humidification does not adequately humidify inspired oxygen to prevent deterioration of MCC, mucus hydration, and pulmonary function. The unheated bubble humidification performed no better than no humidification. Registration at Clinicaltrials.gov (NCT02515786)
Little is known about the longitudinal change in quality of acute asthma care for hospitalized children and adults in the U.S. We investigated whether the concordance of inpatient asthma care with the national guidelines improved over time, identified hospital characteristics predictive of guideline concordance, and determined whether guideline-concordant care is associated with a shorter hospital length-of-stay (LOS).
Analysis of data from two multicenter chart review studies of hospitalized patients aged 2-54 years with acute asthma during two time periods: 1999-2000 and 2012-2013. Outcomes were guideline concordance at the patient- and hospital-levels, and association of patient composite concordance with hospital LOS.
Analytic cohort for the comparison of guideline concordance comprised 1,634 patients: 834 patients from 1999-2000 versus 800 patients from 2012-2013. Over these ∼15 years, inpatient asthma care became more concordant at the hospital-level, with the mean composite score increasing from 74 to 82 (P<.001). However, during 2012-2013, wide variability in guideline concordance of acute asthma care remained across hospitals, with the greatest variation in provision of individualized written action plan at discharge (SD, 36). Guideline concordance was significantly lower in Midwestern and Southern hospitals compared to Northeastern hospitals. After adjusting for severity, patients who received care perfectly concordant with the guidelines had significantly shorter hospital LOS (-14%; 95%CI, -23% to -4%; P=.009).
Between 1999 and 2013, the guideline concordance of acute asthma care for hospitalized patients improved. However, inter-hospital variability remains substantial. Greater concordance with evidence-based guidelines was associated with a shorter hospital LOS.
View All Online First Articles
Become a CHEST member and receive a FREE subscription as a benefit of membership.
Individuals can purchase this article on ScienceDirect.
Individuals can purchase a subscription to the journal.
Individuals can purchase a subscription to the journal or buy individual articles.
Learn more about membership or Purchase a Full Subscription.
Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.


text:
Super Nintendo Games
King Arthur And The Knights Of Justice Questions for Super NintendoHome / Super Nintendo /
Game Questions & Answers (Q&A) service lets you ask questions about video games for game consoles or PC games. So ask your King Arthur And The Knights Of Justice question for Super Nintendo and get answers from real gamers or answer questions and share your insights and experience with the rest of the gaming community.
Boxshot & Details
- Developer: Manley And Associates Inc.
- Publisher: Enix Corporation
- Genre: Action
- Release: Not Set
- ESRB: Not Set
Stuck in this game? Set a specific, clearly defined question and let other gamers answer your question or view answers to previously asked questions. If you think you are an expert then please try to help others with their questions.
Ask a Question
Sponsored Links
Trailers & Gameplay Videos
King Arthur And The Knights Of Justice - Video Walkthrough
- Jun 27, 2014, Views: 43
View All Videos
King Arthur And The Knights Of Justice - Intro
- Jun 27, 2014, Views: 32
More Options
New Released Games
- Super Blue Fighter, (PC)
- Magic Quest, (PC)
- I And Me, (PC)
- Hyposphere, (MAC)
- Hyposphere, (PC)
- Castle Heist: Chapter 1, (PC)
- Wars Of Napoleon, (PC)
- Hack_It, (MAC)
Top Featured Games
- Starlight Drifter, (PC)
- Uncharted 4: A Thief's End, (PS4)
- Downtown Nekketsu Monogatari SP, (3DS)
- LEGO Star Wars: The Force Awakens, (PS4)
- Mirror's Edge, (PS4)
- Deus Ex: Mankind Divided, (PS4)
- Skylanders Battlecast Cards To Life, (AND)
- Mafia 3, (PS4)
- Paragon, (PS4)
Games You May Like
- Pathfinder Adventures, (iOS)
- Dog Mendonca, (iOS)
- Amidakuji Knight, (iOS)
- Gangfort, (iOS)
- Fantasy Story: Lord Of Darkness, (iOS)
- Loud On Planet X, (iOS)
- Yakin, (iOS)
- Fold+, (iOS)
- HeavyRockets, (iOS)
- Star Knight, (iOS)
- Pang Adventures, (iOS)
- Warbits, (iOS)


text:
Camelot Aug 19, 2012 9:51 PM
in response to scottl31
Likely nothing - that's the default option in mail where all domains are mapped to the same user records (e.g. postfix is configured to accept mail for domain1.com, domain2.com and domain3.com - once the domain is parsed they all map to the same user record - namely 'scott').
The solution is to implement the other type of virtual domain hosting at the postfix level. There's extensive online documentation about postfix and virtual hosting. Just be aware that it's almost entirely command-line driven since the Server Admin GUI doesn't delve deeply enough into Postfix's configuration files to handle this.
scottl31 Aug 23, 2012 10:06 PM
in response to Camelot
Hmm.. yet another crazy thing that apple did.
Well, I bought a Mac in the first place to avoid command lines, but I can usually mange if I can see exactly what to enter.
I'm not even sure of the search I'd use to find the answer. If you have any clues, or if you know of a set of commands that work, I'd appreciate it.
I guess my problem with your answer is that I'm not sure what "the other type of virtual domain hosting at the postfix level" is.
Camelot Aug 23, 2012 11:32 PM
in response to scottl31
The 'other type' is standard Postfix Virtual Domains although you might find some of the other online guides easier to read (postfix's documentation leaves a lot to be desired)
scottl31 Aug 24, 2012 7:29 AM
in response to Camelot
I'll see if I can figure it out from that. Thanks!
capaho Aug 24, 2012 8:04 AM
in response to scottl31
You need to create a unique user name for each domain in Workgroup Manager, then add the specific email names in the Short Names list. For example, you would create the user domain1-user, then add email@example.com in the Short Names list, and so on for each domain. The user can then check email by logging in either as domain1-user or email@example.com.
scottl31 Aug 24, 2012 8:50 AM
in response to capaho
Well, I knew a unique user name for each domain would work. But I just want to have one account in WGM, and not have the mail going to me at one domain also go to me at another domain.
capaho Aug 24, 2012 9:21 AM
in response to scottl31
Unfortunately, the solution for the problem you described is as I explained in my previous reply. You need a unique user account in WGM for each domain that will have the same user name for e-mail that needs to go to different domains, with the full e-mail address listed as a short name for the WGM domain account. That's the only way that scenario will work in SL Server.
Camelot Aug 24, 2012 10:03 AM
in response to capaho
That's the only way that scenario will work in SL Server.
Not quite true. That's how it works if you use the GUI admin tools. You can still peek under the hood and configure Postfix directly, based on the links I posted above.
Depending on your level of expertise and time that might not be preferable, but it doea mean that Workgroup Manager model is not the only way.
scottl31 Aug 24, 2012 10:13 AM
in response to Camelot
Camelot, that's what I thought.
it seems crazy that I have to make a separate user account for every domain.
capaho Aug 24, 2012 5:25 PM
in response to Camelot
Of course, you can edit the appropriate configuration files directly from the command line but It's been my experience with SL Server that you can break things unexpectedly if you try to manage user accounts outside of Workgroup Manager.
capaho Aug 24, 2012 5:32 PM
in response to scottl31
I'm not that fond of Workgroup Manager, either, but SL Server is designed to use it for creating and managing network user accounts. Creating a unique user account with an associated mail domain and Short Names for email aliases is the fastest and easiest way to accomplish what you want.
Of course, it's your server, so you can peck through the configuration files if you are that averse to using Workgroup Manager. Post the results once you get it done as it will make a good reference for others who want to use the same approach.
scottl31 Aug 24, 2012 5:44 PM
in response to capaho
I'm not averse to using Workgroup Manager. It just won't let me configure users the way I want and which makes sense.
capaho Aug 24, 2012 7:04 PM
in response to scottl31
Were you able to get it done by editing the configuration files directly?
scottl31 Aug 24, 2012 8:22 PM
in response to capaho
I haven't had a chance to get into it yet, since I'm doing a bunch of getting the kids back to school stuff at the moment. Thanks for asking, and I'll report back when I do something, even if it's wrong.


text:
Nice to meet you here at Audiko, where you can use epic ringtones for your mobile phone. Today we have a ringtone of "Matrix" by Rob D as well as 70 other ringtones by Rob D. "Matrix" is the best track from the "01" album that was made by Rob D at their recording studio together with other 1 tracks. You can listen to all 3 Rob D – "Matrix" ringtone variations available here and download it for free right here. You can also select other 1 albums produced by Rob D for all time. "Matrix" is referred to Soundtrack, and we can offer you a huge amount of Soundtrack compilations absolutely for free. And finally, we have collected lyrics for this track and you can view it here as well. So feel free to browse, listen, download ringtones at Audiko.net. Make your phone sound cool!
Rob D Matrix Ringtone
Similar Ringtones
Browse Genres
Electronic Movie Soundtrack OST Soundtrack
Albums by Rob D
Top ringtones by Rob D
New ringtones
- Marc Anthony - Mark Antony - Vivir Mi Vida
- Unknown - رقت عيناي شوقا
- Pete Yorn/Scarlett Johansson - Relator
- The Monkees - Monkees - I'm a beleiver
- Coldplay - 06 - Trouble
- Ajay Gogavale - 01 Yad Lagla Ga
- Pharrell Williams - Baby
- Omarion Ft Pusha T & Fabolous - Know You Better
- aaliyah - 00-05-aaliyah-more_than_a_woman-rn
- Amy Whinehouse - Valerie (ft. Marc Ronson)


text:
Ono food - from long time ago.
Hamburger, saimin, french fries, real onion rings (gotta ask).
The specials like home cooking. ...view more
Good portions and before 9:30 pm you get complete meal including soup, salad or fruit cup, drink, main course and jello, ice cream or pudding. Pie and cake little extra.
Fast service except when real busy - line out the door sometimes.
Like I said - ono food and nice people.view less
Like Like Drive Inn Restaurant
Today:Open 24 Hours
745 Keeaumoku St,
Honolulu, HI 96814
(808) 941-2515
Business Details
in Business
- BBB Rating:
- Social Links:
- Visit Twitter Page | Visit Facebook Page
- Hours:
Regular Hours
- General Info:
- Like Like Drive Inn was started by James and Alice Nako in Hawaii 1953 and has been in the family for 3 generations. The tradition continues with their daughter, Dora, son in law, Roy Hayashi, and their family. The restaurant has become a local landmark on Oahu, Hawaii, attracting local families & tourist alike. Like Like Drive-Inn has also been officially designated by the State of Hawaii as a place of historic interest. Like Like Drive-Inn is a late night dining restaurant, open 24 hours a day, 7 days a week, serving local American and Asian cuisine. Please go to www.likelikedriveinn.com to view the restaurant and take out menu. Call (808) 941-2515 to please your take out order.
- Services/Products:
- Restaurant
- Payment method:
- cash, debit, master card, visa, discover, jcb
- Location:
- Located across from WalMart, Honolulu
- Neighborhood:
- Ala Moana - Kakaako
- Other Link:
- Other Email:
- Categories:
- Restaurants, American Restaurants, Breakfast, Brunch & Lunch Restaurants, Family Style Restaurants, Take Out Restaurants
- Other Information:
Take Out: Yes
Cuisines: Family Style, American, Omelets
Wi-Fi: No
Wheelchair Accessible: Yes
Alcohol: No
Parking: Lot, Private
Bike Parking: Yes
Attire: Casual
Takes Reservations: No
Outdoor Seating: No
Price Range : Average
Ono food - from long time ago.


text:
There is currently no text in this page. You can search for this page title in other pages, or search the related logs.
Category:For 3 trumpets, timpani, organ (arr)
Free public domain sheet music from IMSLP / Petrucci Music Library
Pages in category "For 3 trumpets, timpani, organ (arr)"
The following 6 pages are in this category, out of 6 total.
- Concerto for 3 Trumpets and Timpani, TWV 54:D3 (Telemann, Georg Philipp)
- Concerto for 3 Trumpets and Timpani, TWV 54:D4 (Telemann, Georg Philipp)
- Gelobet sei der Herr, mein Gott, BWV 129 (Bach, Johann Sebastian)
- Gloria in excelsis Deo, BWV 191 (Bach, Johann Sebastian)
- Gott soll allein mein Herze haben, BWV 169 (Bach, Johann Sebastian)


text:
Exciting to be live blogging from NACCE Miami Dade College Summit
How can we integrate entrepreneurship across the curriculum?
Miami Dade College; Regional Summit
4/29/2016Interested in Internationalizing Your Curriculum?
4/22/2016Key Challenges & Innovative Approaches
4/15/2016NACCE in Chicago
3/14/2016 » 5/6/2016March 2016- NACCE's Entrepreneurship Specialist Certificate Online Training
3/14/2016 » 5/6/2016Bridging College and Community Ecosystems with John Liddy
5/18/2016 » 5/20/2016Incubator Bootcamp
5/19/2016Membership Webinar-Social Entrepreneurship: Infusing Across the Community College Campus
5/20/2016TechHire 21st Century Employability Webinar- May


text:
Part-time personal assistant from Tampa, FL with 10 years of experience and a background check available upon request
Tampa, FL |
10+ years experience
part-time $15-25/hr
Tampa, FL | 10+ years experience | part-time $15-25/hr
Meet Livia
I am interested in working as a Personal Assistant/Shopper. I have years of personal experience, and am a Passionate, Energetic, Spirited Professional with a Positive Attitude, Great Interpersonal Skills, & Extremely Customer Focused who would be a great fit
Has transportation
Provides Transportation Services
Willing to travel
5 miles
Comfortable with pets
Join free today
Sign up now! It only takes a few minutes.
I'd like to...
Who needs care?
What type of ?
When do you need ?
What services do you offer?
What best describes you?
Last, but not least...
Fill in the blanks to create your account.
Thanks—you're almost there.
Create your login below.


text:
All hotels in Shenzhen, China
1 room, 2 adults
3032 Shennan Zhong Road, Shenzhen, Guangdong, 518031, China, 1-877-214-4288
Shenzhen Shanghai Hotel - Shenzhen
Lowest price$58
available on 05/17/16
Shenzhen Shanghai Hotel is a 4-star city center Shenzhen hotel in Futian within a 30-minute walk of Shenzhen Huaqiang North Commercial Circle and Shenzhen City Hall. Shenzhen Museum and Guan Shanyue Art Museum are also within 2 mi (3 km).
This hotel offers free WiFi and wired Internet access, plus a restaurant. Staff are available to provide tour/ticket assistance.
This hotel offers free WiFi and wired Internet access, plus a restaurant. Staff are available to provide tour/ticket assistance.
This is a very decent hotel I have stayed many times. You have to be careful with room…
Bedsheets were never changed. Horrible hotel. Did not refund money for 1 days stay when I…
TripAdvisor Traveller Rating: 4
From 314 reviews
Shenzhen Shanghai Hotel - Shenzhen
Hotel Info: 1-877-214-4288from $58
- Special Room, 2 single beds
- Deluxe Twin Room
- Deluxe Double Room
- Standard Twin Room
- Executive Suite
- Standard Double Room
- Special Room, 1 double bed
- Single Room
- Executive Room
Also popular with travelers from the USA
At a glance
Key facts
Hotel size
- This hotel has 163 rooms
- This hotel is arranged over 12 floors
Required at check in
- Credit card or cash deposit required
- Government-issued photo ID required
Travelling with others
Extra people
- Roll-away beds available, charges may apply*
- Free WiFi and wired Internet access in public areas
- Free WiFi and wired Internet access in rooms
In the hotel
Food and drink
- Breakfast (surcharge)
- Restaurant
Working away
- Business center
- Number of meeting rooms - 2
- Computer station
- Tours/ticket assistance
- Dry cleaning/laundry service
- Luggage storage
- Wedding services
- Number of buildings/towers - 1
- Year Built 1985
- Elevator/lift
- Designated smoking areas
- Library
- Accessible bathroom
- In-room accessibility
- Roll-in shower
In the room
Home comforts
- Air conditioning
- Minibar
- Coffee/tea maker
- Slippers
- Iron/ironing board (on request)
Sleep well
- Blackout drapes/curtains
- Soundproofed rooms
- Turndown service
Freshen up
- Private bathroom
- Rainfall showerhead
- Shower only
- Free toiletries
- Hair dryer
Be entertained
- 25-inch LCD TV
- Cable TV channels
Stay connected
- Desk
- Free newspaper
- Free WiFi
Food and drink
- Refrigerator
- Microwave (on request)
- Free bottled water
- Daily housekeeping
- In-room safe
Shenzhen Shanghai Hotel - Shenzhen's small print
Optional extras
Breakfast is offered for an extra charge of CNY 48 per person (approximately)
We have included all charges provided to us by this hotel. However, charges can vary, for example, based on length of stay or the room you book.


text:
|By Business Wire
Article Rating:
|July 8, 2014 09:11 AM EDT
Emulex Corporation (NYSE:ELX), a leader in network connectivity, monitoring and management, today announced it is delivering high performance 10Gb Ethernet (10GbE) and Gen 5 (16Gb) Fibre Channel (FC) connectivity for Lenovo ThinkServer tower and rack servers with the new OneConnect® OCe14000 family of 10GbE Ethernet Network and Converged Network Adapters (CNAs) and LightPulse® LPe16000 Gen 5 FC Host Bus Adapters (HBAs).
"This announcement represents our first Ethernet design win with Lenovo, and provides the infrastructure required for the demands of today's data centers," said Shaun Walsh, senior vice president of marketing, Emulex. "Our latest generation of Ethernet and Gen 5 Fibre Channel adapters are purpose-built to meet the performance capabilities and workload demands of Lenovo servers. Emulex OCe14000 adapters deliver increased throughput and reduce power consumption and operational expenditures, while addressing next generation workloads such as virtual desktop infrastructure (VDI), Hadoop and server virtualization."
Emulex OneConnect 10GbE adapters and LightPulse Gen 5 FC HBAs offer flexible connectivity and the highest performance, and can be controlled, configured and managed from a single console using Emulex OneCommand® Manager, which consolidates all I/O on a single driver to reduce complexity and ensure stability.
Emulex OneConnect 10GbE Ethernet and Converged Network Adapters enable:
- Industry-leading Server Virtualization Density and Performance: Emulex OCe14000 adapters are the only connectivity solution to deliver consistent line rate throughput, up to 1.5 million I/O operations per second (IOPS) for block storage and hardware offloads that deliver superior CPU and power efficiency, resulting in the ability to increase the number of virtual machines (VMs) per server for Red Hat Linux 6.4, Windows Server 2012 R2 or VMware ESXi 5.5 environments.
- Reduced Data Center Operational Expenditures by Lowering Server Power Consumption: Emulex hardware offload technology can reduce power consumption by up to 50 watts for a typical 2 socket rack optimized server 1, which lowers the server power costs by up to 20 percent (based on average power consumption of 250 watts per a server).
- Optimized Application Performance with Low-latency Connectivity for Virtualization: Emulex has implemented RDMA over Converged Ethernet (RoCE), delivering high performance I/O with reduced latency to applications such as Microsoft SQL Server and targeted network functions such as VM mobility using Windows Server SMB Direct and Linux NFS protocols.
- A 4x Improvement in Packet Performance vs. Previous Generation Adapters: Emulex OCe14000 adapters deliver a 4x performance increase in small packet network performance1, vs. previous generation adapters, which is critical for transaction-heavy and clustered applications such as video content delivery, Web-scale applications and messaging applications.
- Secure and Scalable Cloud Deployments Using Software-defined Networking and Open Technology: Emulex OCe14000 adapters are designed to work with open and industry standard hardware, network virtualization and software environments, including OpenStack-based management and orchestration software, emerging network virtualization using Network Virtualization Generic Routing Encapsulation (NVGRE) (used in Microsoft Hyper-V) and Network Virtualization and Virtual Extensible LAN (VXLAN) (used in VMware NSX). Emulex is also providing 10/40GbE CNAs for the OpenCompute project supporting open and standards-based Web-scale data centers.
Emulex LightPulse Gen 5 FC HBAs enable:
- Superior Gen 5 Fibre Channel Connectivity: Emulex Gen 5 FC HBAs deliver more than 1.2 million I/O operations per second (IOPS) on a single port2, the highest level of Fibre Channel adapter performance available today, and up to 6x greater IOPS per port than the previous generation, enabling better storage performance for cloud and storage intensive applications. Power efficiency is also improved by delivering up to 4x better IOPS per watt of power2.
- Higher Throughput and Low Latency: Emulex Gen 5 FC HBAs provide twice the throughput and up to 75 percent lower latency when compared to current 8GFC adapters without sacrificing CPU efficiency2.
- Increased I/O Bandwidth with PCI Express (PCIe) 3.0 Support: Emulex Gen 5 FC HBAs support PCIe 3.0, which provides a faster I/O bus, more PCIe lanes and increased I/O bandwidth, enabling Emulex Gen 5 FC technology to provide optimal performance for applications, such as virtualization and database management systems, by matching the performance capabilities of server platforms based on the new Intel Xeon processor E5-2600 V2 product family.
- Improved Quality of Service with Emulex Gen 5 Flash Services: Gen 5 Flash Services includes ExpressLane™, which provides Quality of Service (QoS) capabilities for flash/solid state disk (SSD)-based storage and Emulex CrossLink™, which provides in-band message passing between server nodes, delivering optimized performance using lossless, standards-based FC protocols.
"Our goal is to address the real-world IT needs of our customers' business-critical workloads with enterprise-class, open industry-standard solutions that provide the ideal balance of performance and features, and ease-of-use and integration with our enterprise product offerings," said Darrel Ward, vice president and general manager, Enterprise Product Group, Lenovo. "We are pleased to partner together to provide high performance Fibre Channel and 10GbE adapters that offer integrated ease-of-use with Lenovo ThinkServer tower and rack servers to our customers."
Emulex OneConnect 10GbE Ethernet and Converged Network Adapters and LightPulse Gen 5 FC HBAs are now available for Lenovo ThinkServer TD340 tower, RD340/RD440 and RD540/RD640 rack servers. Visit the Lenovo web site for ordering information.
1. Based
on Emulex Implementers Lab blog
2. Demartek Emulex LPe16000B 16Gb Fibre Channel HBA Evaluation, October 2012
Tweet This: Emulex #10GbE and Gen 5 #FibreChannel Connectivity Enhance @Lenovo #ThinkServer family: http://ow.ly/yHqZ5
Follow Emulex on Twitter.
About Emulex
Emulex, a leader in network connectivity, monitoring and management, provides hardware and software solutions for global networks that support enterprise, cloud, government and telecommunications. Emulex's products enable unrivaled end-to-end application visibility, optimization and acceleration. The Company's I/O connectivity offerings, including its line of ultra high-performance Ethernet and Fibre Channel-based connectivity products, have been designed into server and storage solutions from leading OEMs, including Cisco, Dell, EMC, Fujitsu, Hitachi, HP, Huawei, IBM, NetApp and Oracle, and can be found in the data centers of nearly all of the Fortune 1000. Emulex's monitoring and management solutions, including its portfolio of network visibility and recording products, provide organizations with complete network performance management at speeds up to 100Gb Ethernet. Emulex is headquartered in Costa Mesa, Calif., and has offices and research facilities in North America, Asia and Europe. For more information about Emulex (NYSE:ELX) please visit http://www.Emulex.com.
"Safe Harbor" Statement
"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: With the exception of historical information, the statements set forth above, contain forward-looking statements that involve risk and uncertainties. We expressly disclaim any obligation or undertaking to release publicly any updates or changes to these forward-looking statements that may be made to reflect any future events or circumstances. We wish to caution readers that a number of important factors could cause actual results to differ materially from those in the forward-looking statements. These factors include the possibility that all or a substantial portion of the cost savings targeted by us will not be realized on a timely basis or at all even though we expect to incur charges relating to the cost saving initiative and that the share repurchases implemented by us may not be completed in whole or in part or within the expected timeframe. The assumptions on which the cost savings, share repurchase and capital return goals and expectations are based necessarily involve judgments with respect to, among other things, economic, competitive and financial market conditions and the impact of the cost savings initiative on our customers, all of which are difficult or impossible to predict and many of which are beyond the Company's control. Furthermore, our proposed changes to the membership of our board of directors may not have the desired effect in helping us achieve and implement our business and strategic goals. These factors also include the possibility that we may not realize the anticipated benefits from the acquisition of Endace Limited on a timely basis or at all, and may be unable to integrate the technology, operations and personnel of Endace into our existing operations in a timely and efficient manner. In addition, intellectual property claims, with or without merit, could result in costly litigation, cause product shipment delays, require us to indemnify customers, or require us to enter into royalty or licensing agreements, which may or may not be available. Furthermore, we have in the past obtained, and may be required in the future to obtain, licenses of technology owned by other parties. We cannot be certain that the necessary licenses will be available or that they will be obtainable on commercially reasonable terms. If we were to fail to obtain such royalty or licensing agreements in a timely manner and on reasonable terms, our business, results of operations and financial condition could be materially adversely affected. Lawsuits present inherent risks, any of which could have a material adverse effect on our business, financial condition, or results of operations. Such potential risks include continuing expenses of litigation, loss of patent rights, monetary damages, injunctions against the sale of products incorporating the technology in question, counterclaims, attorneys' fees, incremental costs associated with product or component redesigns, liabilities to customers under reimbursement agreements or contractual indemnification provisions, and diversion of management's attention from other business matters. In addition, the fact that the economy generally, and the network connectivity and visibility market segments specifically, have been in a state of uncertainty makes it difficult to determine if past experience is a good guide to the future and makes it impossible to determine if markets will grow or shrink in the short term. Continued weakness in domestic and worldwide macro-economic conditions, related disruptions in world credit and equity markets, and the resulting economic uncertainty for our customers, as well as the overall network connectivity and visibility markets, has and could continue to adversely affect our revenues and results of operations. As a result of these uncertainties, we are unable to predict our future results with any accuracy. Other factors affecting these forward-looking statements include but are not limited to the following: faster than anticipated declines in the storage networking market, slower than expected growth of the converged networking market or the failure of our Original Equipment Manufacturer (OEM) customers to successfully incorporate our products into their systems; our dependence on a limited number of customers and the effects of the loss of, decrease in or delays of orders by any such customers, or the failure of such customers to make timely payments; the emergence of new or stronger competitors as a result of consolidation movements in the market; the timing and market acceptance of our products or our OEM customers' new or enhanced products; costs associated with entry into new areas of the network connectivity and visibility markets; the variability in the level of our backlog and the variable and seasonal procurement patterns of our customers; any inadequacy of our intellectual property protection and the costs of actual or potential third-party claims of infringement and any related indemnity obligations or adverse judgments; the effect of any actual or potential unsolicited offers to acquire us; proxy contests or the activities of activist investors; impairment charges, including but not limited to goodwill and intangible assets; changes in tax rates or legislation; the effects of acquisitions; the effects of terrorist activities, natural disasters, and any resulting disruption in our supply chain or customer purchasing patterns or any other resulting economic or political instability; the highly competitive nature of the markets for our products as well as pricing pressures that may result from such competitive conditions; the effect of rapid migration of customers towards newer, lower cost product platforms; transitions from board or box level to application specific integrated circuit (ASIC) solutions for selected applications; a shift in unit product mix from higher-end to lower-end or mezzanine card products; a faster than anticipated decrease in the average unit selling prices or an increase in the manufactured cost of our products; delays in product development; our reliance on third-party suppliers and subcontractors for components and assembly; our ability to attract and retain key technical personnel; our ability to benefit from our research and development activities as well as government grants related thereto; our dependence on international sales and internationally produced products; changes in accounting standards; and any resulting regulatory changes on our business. These and other factors could cause actual results to differ materially from those in the forward-looking statements and are discussed in our filings with the Securities and Exchange Commission, including our recent filings on Forms 10-K and 10-Q, under the caption "Risk Factors."
All trademarks, trade names, service marks, and logos referenced herein belong to their respective companies.
The IoT has the potential to create a renaissance of manufacturing in the US and elsewhere. In his session at 18th Cloud Expo, Florent Solt, CTO and chief architect of Netvibes, will discuss how the expected exponential increase in the amount of data that will be processed, transported, stored, and accessed means there will be a huge demand for smart technologies to deliver it. Florent Solt is the CTO and chief architect of Netvibes. Prior to joining Netvibes in 2007, he co-founded Rift Technol...
Apr. 28, 2016 07:00 PM EDT Reads: 1,460
Join IBM June 8 at 18th Cloud Expo at the Javits Center in New York City, NY, and learn how to innovate like a startup and scale for the enterprise. You need to deliver quality applications faster and cheaper, attract and retain customers with an engaging experience across devices, and seamlessly integrate your enterprise systems. And you can't take 12 months to do it.
Apr. 28, 2016 04:45 PM EDT Reads: 1,717
This is not a small hotel event. It is also not a big vendor party where politicians and entertainers are more important than real content. This is Cloud Expo, the world's longest-running conference and exhibition focused on Cloud Computing and all that it entails. If you want serious presentations and valuable insight about Cloud Computing for three straight days, then register now for Cloud Expo.
Apr. 28, 2016 04:30 PM EDT Reads: 1,606
IoT device adoption is growing at staggering rates, and with it comes opportunity for developers to meet consumer demand for an ever more connected world. Wireless communication is the key part of the encompassing components of any IoT device. Wireless connectivity enhances the device utility at the expense of ease of use and deployment challenges. Since connectivity is fundamental for IoT device development, engineers must understand how to overcome the hurdles inherent in incorporating multipl...
Apr. 28, 2016 02:45 PM EDT Reads: 1,354
Machine Learning helps make complex systems more efficient. By applying advanced Machine Learning techniques such as Cognitive Fingerprinting, wind project operators can utilize these tools to learn from collected data, detect regular patterns, and optimize their own operations. In his session at 18th Cloud Expo, Stuart Gillen, Director of Business Development at SparkCognition, will discuss how research has demonstrated the value of Machine Learning in delivering next generation analytics to im...
Apr. 28, 2016 02:30 PM EDT Reads: 1,542
Manufacturers are embracing the Industrial Internet the same way consumers are leveraging Fitbits – to improve overall health and wellness. Both can provide consistent measurement, visibility, and suggest performance improvements customized to help reach goals. Fitbit users can view real-time data and make adjustments to increase their activity. In his session at @ThingsExpo, Mark Bernardo Professional Services Leader, Americas, at GE Digital, will discuss how leveraging the Industrial Interne...
Apr. 28, 2016 01:15 PM EDT Reads: 1,075
The paradigm has shifted. A Gartner survey shows that 43% of organizations are using or plan to implement the Internet of Things in 2016. However, not just a handful of companies are still using the old-style ad-hoc trial-and-error ways, unaware of the critical barriers, paint points, traps, and hidden roadblocks. How can you become a winner? In his session at @ThingsExpo, Tony Shan will present a methodical approach to guide the holistic adoption and enablement of IoT implementations. This ov...
Apr. 28, 2016 01:00 PM EDT Reads: 1,489
SYS-CON Events announced today that Stratoscale, the software company developing the next generation data center operating system, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Stratoscale is revolutionizing the data center with a zero-to-cloud-in-minutes solution. With Stratoscale's hardware-agnostic, Software Defined Data Center (SDDC) solution to store everything, run anything and scale everywhere...
Apr. 28, 2016 12:45 PM EDT Reads: 1,441
Angular 2 is a complete re-write of the popular framework AngularJS. Programming in Angular 2 is greatly simplified – now it's a component-based well-performing framework. This immersive one-day workshop at 18th Cloud Expo, led by Yakov Fain, a Java Champion and a co-founder of the IT consultancy Farata Systems and the product company SuranceBay, will provide you with everything you wanted to know about Angular 2.
Apr. 28, 2016 12:15 PM EDT Reads: 1,590
Digital payments using wearable devices such as smart watches, fitness trackers, and payment wristbands are an increasing area of focus for industry participants, and consumer acceptance from early trials and deployments has encouraged some of the biggest names in technology and banking to continue their push to drive growth in this nascent market. Wearable payment systems may utilize near field communication (NFC), radio frequency identification (RFID), or quick response (QR) codes and barcodes...
Apr. 28, 2016 12:00 PM EDT Reads: 525
SYS-CON Events announced today that Men & Mice, the leading global provider of DNS, DHCP and IP address management overlay solutions, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. The Men & Mice Suite overlay solution is already known for its powerful application in heterogeneous operating environments, enabling enterprises to scale without fuss. Building on a solid range of diverse platform support,...
Apr. 28, 2016 11:30 AM EDT Reads: 2,162
You deployed your app with the Bluemix PaaS and it's gaining some serious traction, so it's time to make some tweaks. Did you design your application in a way that it can scale in the cloud? Were you even thinking about the cloud when you built the app? If not, chances are your app is going to break. Check out this webcast to learn various techniques for designing applications that will scale successfully in Bluemix, for the confidence you need to take your apps to the next level and beyond.
Apr. 28, 2016 11:00 AM EDT Reads: 1,384
The increasing popularity of the Internet of Things necessitates that our physical and cognitive relationship with wearable technology will change rapidly in the near future. This advent means logging has become a thing of the past. Before, it was on us to track our own data, but now that data is automatically available. What does this mean for mHealth and the "connected" body? In her session at @ThingsExpo, Lisa Calkins, CEO and co-founder of Amadeus Consulting, will discuss the impact of wea...
Apr. 28, 2016 10:30 AM EDT Reads: 521
Whether your IoT service is connecting cars, homes, appliances, wearable, cameras or other devices, one question hangs in the balance – how do you actually make money from this service? The ability to turn your IoT service into profit requires the ability to create a monetization strategy that is flexible, scalable and working for you in real-time. It must be a transparent, smoothly implemented strategy that all stakeholders – from customers to the board – will be able to understand and comprehe...
Apr. 28, 2016 10:15 AM EDT Reads: 927
So, you bought into the current machine learning craze and went on to collect millions/billions of records from this promising new data source. Now, what do you do with them? Too often, the abundance of data quickly turns into an abundance of problems. How do you extract that "magic essence" from your data without falling into the common pitfalls? In her session at @ThingsExpo, Natalia Ponomareva, Software Engineer at Google, will provide tips on how to be successful in large scale machine lear...
Apr. 28, 2016 10:00 AM EDT Reads: 704
SYS-CON Events announced today that Ericsson has been named "Gold Sponsor" of SYS-CON's @ThingsExpo, which will take place on June 7-9, 2016, at the Javits Center in New York, New York. Ericsson is a world leader in the rapidly changing environment of communications technology – providing equipment, software and services to enable transformation through mobility. Some 40 percent of global mobile traffic runs through networks we have supplied. More than 1 billion subscribers around the world re...
Apr. 28, 2016 10:00 AM EDT Reads: 668
SYS-CON Events announced today that Fusion, a leading provider of cloud services, will exhibit at SYS-CON's 18th International Cloud Expo®, which will take place on June 7-9, 2016, at the Javits Center in New York City, NY. Fusion, a leading provider of integrated cloud solutions to small, medium and large businesses, is the industry's single source for the cloud. Fusion's advanced, proprietary cloud service platform enables the integration of leading edge solutions in the cloud, including cloud...
Apr. 28, 2016 09:30 AM EDT Reads: 2,494
There is an ever-growing explosion of new devices that are connected to the Internet using "cloud" solutions. This rapid growth is creating a massive new demand for efficient access to data. And it's not just about connecting to that data anymore. This new demand is bringing new issues and challenges and it is important for companies to scale for the coming growth. And with that scaling comes the need for greater security, gathering and data analysis, storage, connectivity and, of course, the...
Apr. 28, 2016 09:00 AM EDT Reads: 518
The IETF draft standard for M2M certificates is a security solution specifically designed for the demanding needs of IoT/M2M applications. In his session at @ThingsExpo, Brian Romansky, VP of Strategic Technology at TrustPoint Innovation, will explain how M2M certificates can efficiently enable confidentiality, integrity, and authenticity on highly constrained devices.
Apr. 28, 2016 09:00 AM EDT Reads: 940
We've worked with dozens of early adopters across numerous industries and will debunk common misperceptions, which starts with understanding that many of the connected products we'll use over the next 5 years are already products, they're just not yet connected. With an IoT product, time-in-market provides much more essential feedback than ever before. Innovation comes from what you do with the data that the connected product provides in order to enhance the customer experience and optimize busi...
Apr. 28, 2016 08:45 AM EDT Reads: 782


text:
Below is a list of the most popular customer scuba gear reviews for Kids Gear, Kids Neoprene and Skins. Click the product name to view more reviews and details about that product. For longer reviews, click the View Full Review link next to a review to read the whole review.
You can see the most helpful scuba gear reviews for kids gear below. Scuba.com offers gear reviews from the following manufacturers: Aqua Lung, Aqua Lung Sport., Bare, Deep See, Divegear, H2O, Henderson, Neosport by Henderson, Pinnacle, Scubamax and more...
Reviewer: Cory Hansonchildrens wetsuit - I originally called for assistance on ordering and sizing the suit for my son. The salesperson was very helpful. I was very please with my help. The suit itself was a bit mis-proportioned. The arms seem to be made a bit larger than necessary. The body part of the suit fit well for him, but, the arms are a bit loose fitting. It does work well to keep him warm on those cool days. He likes it very much. Over all I am happy with the purchase.
Reviewer: janna m.Great! - I was reluctant to buy the size based off of the size chart, as most companies sizes run small. But the one I ordered was perfect for my son. When the pool water is chilly in Spring and Fall, he puts this suit on and its just the right amount of shock-resistance. I will order from these guys again next year for sure!
Reviewer: eileen m.Fit for a child - Easy on and off... fits a 50 inch tall, 53 pound girl... ccomfortable neck, good quality zips, sturdy knee pads.... good price and good quality.
Reviewer: Clive C.Great KIds wetsuit - The sizing chart worked great and the fit was good right out of the box. She has worn it multiple times so far and it is working as advertised.
Reviewer: Ron B.Good quality - This is a well made wetsuit for kids. My daughter uses this in the winter here in Okinawa under her 3 mm full suit which keeps her torso warm. In the summer shell use it by itself as the waters here are in the 80s by then. She is 10 years old, 150 cm tall and thin yet the size large is a little too tight for her. It will maybe last her through the summer so I wish I would have gotten her an XL. She is probably more of an adult xs or s than a kids large, but just beware that is seems to run small. And you cant beat the price.
Reviewer: Cynthia D.Good - This item is great for my grandson .
Reviewer: michael l.Bare 1mm Kids Dolphin Floaty Shorty Wetsuit Review - $34.95 - Scuba Gear Customer Reviews - I got this one for my daughter who is just learning to swim. It has pads on the upper torso that can be removed. They dont provide a lot of lift but more "persuasion". We used it every day in Key Largo and it provided great protection from the sun. She loves it
Reviewer: CUC N.3mm Childs Thermoprene Shorty Wetsuit - I purchased 3 different wetsuit, kept this and returned the other two. This 3mm keep my daughter warmer. She loves it and wants to wear it all the time. The design is cute. My daughter is very tiny so its loose but thats not a problem. The collar is a little high, if its shorter, it would be perfect.
Reviewer: Michael S.Pinnacle 3mm Youth Spirit Titanium Shorty Wetsuit Review - $59.95 - Scuba Gear Customer Reviews - Awesome wetsuit !! Bought for my daughter, who is a child with special needs. It allowed her to stay in the lake longer than she would normally. When she finally got out , she wasnt cold like we have come to expect.
Reviewer: steve linAqua Lung. 7mm Kids Tsunami Wetsuit Black/Blue 2XLarge - It his is definitely shtick and wa suit, able to withstand anything we have in SoCal during any season. Only thing is, the neoprene is not as soft and elastic as some of the higher quality surf wetsuits, like the psycho freak. But this is a dive suit, so it doesnt have to be as flexible and elastic as surf suits
Reviewer: LINDSAY H.Concerned with the way it wears - overall very happy with this wetsuit, however i am concerned with the way it is wearing. i wore this wetsuit one day on 2 dives and it already got worn/nubby on the arm and shoulder area where the bcd rubs. the material pilled and it looked like i had worn it a lot. the dive pros i was with said their wetsuits that theyve worn on 500+ dives havent even done that. im concerned with how this issue will get as i wear it more and am not happy with the way it looks.
Reviewer: Nancy HaraisaGreat quality boot - This is actually as good quality as the boot I use for scuba diving, sized down for my 5 year old. Its a little big for her yet, but she used it in Hawaii on the beaches and walking around in case there was coral on the shores. She was happier using these than the aqua socks, even though theyre big and black. Since the rest of the family is divers, my younger one felt like she was part of the dive group. If youre wanting a nice thick boot and will be using it at least a couple times a year or live on the beach, its money well spent since the boot is likely to last longer than most other brands and models. If youre looking for something thats just for the once in a lifetime vacation,...View Full Review
View all Scuba Gear Reviews View all Kids Gear - Kids Neoprene and Skins


text:
Does this webpage look like it will be helpful to you? Please tell us why.
What problem are you trying to fix today?
Thank you for helping make our site better.
If you know the ice maker repair part you need, you can browse the list of all parts on the 3KUIS185V0, or you can search by name or part description. You can also find your part by where it is located on the 3KUIS185V0 by selecting a section below. If you're not sure which part you need, you can narrow your search by selecting a common symptom and we'll show you the repair parts most likely to fix your ice maker. We've also included any installation videos we have for 3KUIS185V0 parts. Installation instructions provided by other do-it-yourselfers will help guide you through your repair.
This light switch is triggered by the door opening and closing.
This tubing is 1/4'' in diameter and comes with 2 inserts. This tubing may be longer than the original, and may have to be cut.
This screw is sold individually.
This compression nut is used with the plastic water line of the icemaker assembly.
These inserts are used with 1/4 inch plastic tubing.
Sold individually.
Used on freestanding ice makers.
This part helps prevent the evaporator from freezing over and also determines the thickness of the ice.
Fixed by these parts
All brand logos are trademarks of their respective owners.
The PartSelect logo is a Registered Trademark of Atlantic Laundry Centres, Ltd.
Copyright © 1999-2016 , Eldis Group Partnership. All rights reserved.


text:
When the movie "A Perfect Storm" came on television a few years ago, the rolling waves, the pounding rain and the sheer guts and determination of the fishing crew immediately swept me into the story.
As the drama continued, as the waves grew and the wind speed increased, I watched for the sure-to-come rescue. Even after the crew was swept overboard, their yellow rain slickers mere specks on the vast and violent ocean, I scanned those towering waves, confident that their heroic rescue was imminent.
Then the film credits began to roll.
I turned to Danny in astonishment. "That's it?" I asked, incredulous. "They're all dead? They all died?!?"
Not nearly as emotionally invested as I was in their story, he shrugged and said, "Yeah. I guess."
When I found out that the story was based on true life events, I was even more dismayed. I wanted a storybook ending, not a real life tragedy come to the big screen.
As impressive as the waves were, as convincing as the actors were in assuming their roles, in spite of the compelling storytelling, I still regret watching it, because it ended so badly.
I took a little side journey last year, investigating someone else's tale to tell. The tale began badly. Well, actually it ended badly, very badly, and I knew how it ended before I knew it how it came to be. As I investigated it, I couldn't get the ending out of my mind. Every word I read, every page I turned, was colored by the known outcome and I struggled through every slip of paper presented.
Usually a brisk reader, I spent months poring over the records written by foster parents, psychiatrists, social workers and other principle players in the modern-day tragedy.
I kept waiting for the villain to appear. Knowing how the story ended meant there had to be a villain. Page after page after page was turned -- still no villain. Only victims, none of whom yet knowing that they were, or soon would be, victims. When they wrote their reports, when they entered each day's events in their journals, they had no idea how the story would end. In fact, each one was doing all that was in them to bring about a joyful, storybook ending.
I really wanted there to be a villain. The cast of characters, victimized in ways unimaginable, deserved a villain, someone to blame, someone to judge.
It is part and parcel of our created identity, this thirst for justice. It manifests itself early on in human development. Toddlers watch in rapt attention as milk is poured into their sippy cups, their keen eyesight quick to notice even a quarter of an inch difference in levels. Justice. Fair play.
It scarcely matters how large or gaily wrapped a Christmas present is, if there is more than one child in the house, it's the number of gifts that are counted and compared.
As we mature as human beings and begin to witness man's inhumanity to man, our inborn thirst for justice only intensifies, even if we are not directly impacted by the injustice. For me, it was the Civil Rights movement, played out nightly on the news while I grew up.
This thirst for justice is the primary reason for the multitude of laws in our land. "This is wrong and ought not to be!" we cry and so a law is carefully crafted and put on the books. (All right, the laws aren't always as carefully crafted as they ought to be, but that's a tale for another day.)
All of this bears witness to a fundamentally human trait, one that I have never seen duplicated in the animal kingdom.
Jesus promised in Matthew 5:6 "Blessed are those who hunger and thirst for righteousness, for they shall be filled." The New Living Translation renders it thus: "God blesses those who hunger and thirst for justice, for they will be satisfied."
But what happens if justice is out of reach, if the villain is no villain at all, but rather another tragic victim? What happens then? How are the scales of justice to be brought back into balance?
The same audience that heard Jesus promise satisfaction for those who hunger and thirst for righteousness, also heard his admonition "Do not judge, or you too will be judged. For in the same way you judge others, you will be judged, and with the measure you use, it will be measured to you." in Matthew 7:1 and 2
Our hunger and thirst for righteousness is a gift from God. Our desire to see justice done mirrors his character and testifies to our origins in him. But we remain mere men. We are not God. This was the thrust of Jesus' admonition. In the very next verses in Matthew, he points out where our attention needs to be. "Why do you look at the speck of sawdust in your brother's eye and pay no attention to the plank in your own eye? How can you say to your brother, 'Let me take the speck out of your eye,' when all the time there is a plank in your own eye? You hypocrite, first take the plank out of your own eye, and then you will see clearly to remove the speck from your brother's eye."
There are far too many times, in this present age, when true justice is beyond our reach. There are innocent men locked up for years, some never tasting freedom again. There are evil, wicked men walking amongst us, no one able to cage them.
And there are mothers, fathers, sons and daughters taken from us in violent acts of desperation, the true villain escaping even the smallest measure of justice.
For now.
"... I am he who searches hearts and minds, and I will repay each of you according to your deeds." Revelation 2:23(b) (NIV)
I don't have all the answers, but I know the One who does. Let's walk together for awhile and discover Him; together.


text: Fabijonas, Bruce R.; Olver, F. W. J. On the reversion of an asymptotic expansion and the zeros of the Airy functions. (English) Zbl 1053.33003 SIAM Rev. 41, No. 4, 762-773 (1999). Summary: The general theories of the derivation of inverses of functions from their power series and asymptotic expansions are discussed and compared. The asymptotic theory is applied to obtain asymptotic expansions of the zeros of the Airy functions and their derivatives, and also of the associated values of the functions or derivatives. A Maple code is constructed to generate exactly the coefficients in these expansions. The only limits on the number of coefficients are those imposed by the capacity of the computer being used and the execution time that is available. The sign patterns of the coefficients suggest open problems pertaining to error bounds for the asymptotic expansions of the zeros and stationary values of the Airy functions. Cited in 1 ReviewCited in 7 Documents MSC:33C10Bessel and Airy functions, cylinder functions, ${}_0F_1$33F05Numerical approximation and evaluation of special functions41A60Asymptotic approximations, asymptotic expansions (steepest descent, etc.)65D20Computation of special functions, construction of tablesKeywords:Airy functions; asymptotic expansions; error bounds; inversion theorems; Lagrange's reversion theorem; phase principle; principle of the argument; symbolic computation; zeros Software:Algorithm 786; Maple BibTeX Full Text: DOI


text:
Twilight and Harry Potter Dolls Look Incredibly Lifelike
15 Original Netflix Series That You Should Be Watching
20 Movies You Need To Watch At Home This Week
The Worst Upcoming Movies Of The Next Five Years
Where Are They Now: The Gay Girls of ANTM
The Long, Troubled Future History of 'Back to The Future Part IV'
7 TV Time Jumps That Were Done Right
Game Of Thrones Season 6 Delayed!
Movies You Didn't Know Were Blatant Rip-Offs
Check out Emily Blunt as Evil Elsa
Sorry, Lamar: Khloe Kardashian, James Harden Seen Together At Hollywood Club
This Japanese Star Wars: The Force Awakens Trailer May Have Dropped a Huge Spoiler
10 Toughest Female Characters On TV
The Girl With Dungeons and Dragons Tattoo
8 Historical Facts That Will Change Your Concept of Time Forever
New Wonder Woman Photo Revealed as Filming Begins, Cast Announced
Star Trek: New Series Could Run Many Seasons
The Best Movies of Summer 2015
Game of Thrones Spoilers: Season 6 Parade of Lies
10 Celebrities Who Quit Hollywood Forever
Jessica Jones: Marvel's Greatest Risk Or Its Greatest Evolution?
6 Films That Prove a Great Fantastic Four Movie is Possible
12 Other Movies Where Avengers Assemble
The 10 Fall TV Shows We Can't Wait To Watch
10 TV Cancellations Still Worth Raving About
Blindspot: Series Ending Mapped Out in Case of Cancellation
Best TV Series of All Time
Your Guide to the 20+ Superheroes and Villains Joining The CW-Verse This Fall
The Best Action Films of 2015
New Mega-Trailer Shows How Little We've Seen of Star Wars: The Force Awakens


text:
5027 Views 13 Replies Latest reply: Aug 9, 2008 11:27 PM by Courcoul
Allan Jones Jul 28, 2008 4:49 PM
in response to yatesrCan you post a link to that specific RAM so people can review the specs??
Smerky Jul 28, 2008 9:59 PM
in response to yatesrKinston's line of PC2-6400:
Neither of them specify if it would be directly compatible with your MBP. I'm going to call Crucial tomorrow to find out what they say since I'm interested in knowing myself.
Smerky Jul 29, 2008 7:50 AM
in response to yatesrI did an online chat with a rep from Crucial and they said that the current MacBook Pro can not handle the speed of the PC2-6400. That's rather unfortunate.
Courcoul Jul 29, 2008 9:19 AM
in response to SmerkyWell, as a consolation, if you have a new generation MBP, you can always use the new 4GB 667 DIMMs. You won't get the high speed, but you will get 8 whopping GB of RAM in there...
There was an article in here awhile back, where someone reported results of testing the new big DIMMs on the Feb'80 MBP and confirming that the system was successfully able to handle the full 8GB, although this is not officially supported by Apple. The Penryn is really a dual 32/64 bit processor.
Billydelp4 Jul 29, 2008 10:45 AM
in response to Courcouli thought all the intel processors were both 32/64 bit? I was told by an apples specialist at the store that mine had a 64 bit processor running a 64 bit OS with leopard. Was he wrong? I am July 07 so the Santa Rosa model 2.2
Smerky Jul 29, 2008 9:41 PM
in response to Billydelp4They are dual....Why are you confused? Nobody said anything about them not being dual 32/64 bit.
Richard Pini Jul 31, 2008 10:56 AM
in response to SmerkyHm. In the system profiler for my MBP (2.5 GHz Penryn, bought mid June) it lists the bus speed as 800 MHz, though the 2 1-gig sticks are 667 MHz DDR2 SDRAM. If the bus speed is given as 800 MHz, I wonder why it would not handle 800 MHz memory?
Smerky Jul 31, 2008 11:16 AM
in response to Richard PiniAccording to Crucial they claim that they tested with the current MDP but they say that the MDP does not support 800Mhz parts.
3zzy Aug 9, 2008 10:48 PM
in response to SmerkyI've the latest MBP 17"(version 4,1), will it support 800 Mhz?
Courcoul Aug 9, 2008 11:04 PM
in response to Richard Pini
If the bus speed is given as 800 MHz, I wonder why it would not handle 800 MHz memory?
[This pretty picture|http://developer.apple.com/documentation/HardwareDrivers/Conceptual/15i nMacBookPro0802/Articles/ProductDeveloperNote.html#//appleref/doc/uid/TP40007348-BCIGAACJ] will give you an idea of why the bus is 800MHz but memory has to run at 667MHz, until the supporting chipset gets upgraded to the Montevina platform, sometime later in this year. Same thing goes for [the 17 in MBP, Feb'08 edition|http://developer.apple.com/documentation/HardwareDrivers/Conceptual/17i nMacBookPro_0802/Articles/ProductDeveloperNote.html].
3zzy Aug 9, 2008 11:20 PM
in response to CourcoulErm..not really. The guy who tested 8GB RAM concluded:
"Unfortunately after running the MacBook Pro for almost 24 hours, it isn't looking good. One of the key scenarios for wanting to move to 8GB isn't working worth a ****. I'm talking about virtualization.
...Assuming by pulling the memory out of the box, things settle down and perform properly, then Apple, VMWare, Parallels and Kingston have some work to do. At that point it would not be apparent if the 4GB sticks are in fact faulty, or OS X needs a fix, or Fusion and/or Parallels need a fix. This would certainly be out of my hands for any further testing."
Wish it did work though.
Courcoul Aug 9, 2008 11:27 PM
in response to 3zzyBummer... When I read the thread, he hadn't gotten to the bad part yet. But then, we are really getting just what we paid for: the current model MBP's are only supported with up to 4GB RAM. Apple and the others must be busily working, but on the next generation that will support 8GB and many other goodies.